AdComms – Is FDA Getting Less Advice?
As more drugs are being approved, is FDA getting less advice than in the past? FDA maintains a vast network of outside advisors to provide input and
As more drugs are being approved, is FDA getting less advice than in the past? FDA maintains a vast network of outside advisors to provide input and
Vaccination has been robust. Cities are opening up. Plans are underway for back-to-school. Travel is robust. Offices are cautiously re-opening.
Today, FDA published notice in the Federal Register of an upcoming meeting of the Arthritis Drugs Advisory Committee that will be held May 6. The
Each year in January, it is relevant to look back on the activities of FDA during the course of the previous year and look at how it was the same or
First of all, we are having a bit of a crisis with our crisis. As we appear to be moving into yet another wave of COVID-19 infections, and as
I don’t usually publish the scheduling of an AdComm with a blog posting. But this one merits one. With fewer than the usual minimum of fifteen
Virtually everyone is going virtual. Even in February, which seems like a very long time ago, many organizers began either postponing or canceling
Empty FDA Advisory Committee Meeting Room Earlier this month I published a blog posting that raised questions related to the potential for disruption
Has FDA been holding enough AdComms? There have been a large number of drugs approved in the past year, but there has not been a corresponding